Optilume is a drug-coated balloon catheter that dilates urethral strictures while simultaneously delivering paclitaxel — a medication that inhibits scar tissue regrowth. Unlike traditional dilation or direct vision internal urethrotomy (DVIU), which often have high recurrence rates, Optilume targets the underlying biology of stricture formation.
The technology combines mechanical dilation (to widen the narrowed segment) with local drug delivery (to prevent re-scarring). This dual-action approach offers better long-term outcomes with minimal invasiveness.